Organon (OGN) Total Liabilities (2020 - 2026)
Organon (OGN) posted Total Liabilities of $12.2 billion for Q2 2026, up 0.65% on a QoQ basis from $12.1 billion in Q1 2026, and down 4.66% year-over-year from $12.8 billion in Q2 2025.
Analysis
Organon (OGN) Total Liabilities (2020 - 2026) Analysis & Trends
Organon has reported Total Liabilities for 7 years, with the latest figure at $12.2 billion in Q2 2026.
- On a quarterly basis, Total Liabilities fell 4.66% year-over-year to $12.2 billion in Q2 2026; TTM through Jun 2026 was $12.2 billion, a 4.66% decrease from a year earlier, with the FY2025 full-year figure at $12.1 billion, down 4.07% from the prior year.
- Total Liabilities was $12.2 billion for Q2 2026 at Organon, up from $12.1 billion in the prior quarter.
- The five-year high for Total Liabilities was $12.8 billion in Q2 2025, with the low at $11.5 billion in Q1 2023.
- Average Total Liabilities over 5 years is $12.0 billion, with a median of $12.1 billion recorded in 2024.
- The largest YoY upside for Total Liabilities was 140.79% in 2022 against a maximum downside of 11.19% in 2022.
- Over 5 years, Total Liabilities stood at $11.8 billion in 2022, then increased by 2.37% to $12.1 billion in 2023, then climbed by 4.13% to $12.6 billion in 2024, then slipped by 4.07% to $12.1 billion in 2025, then gained by 0.47% to $12.2 billion in 2026.
- The last three Total Liabilities figures came in at $12.2 billion (Q2 2026), $12.1 billion (Q1 2026), and $12.1 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | 116.09 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | 141.05 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | 23.74 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | 80.09 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | 115.64 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | 69.15 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | 1.72 Bn |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | 1.53 Bn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | 819.80 Mn |
| 10 | Organon | 3.58 Bn | 2.45 Bn | 847.00 Mn | 12.17 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.17 Bn |
| Mar 31, 2026 | 12.09 Bn |
| Dec 31, 2025 | 12.12 Bn |
| Sep 30, 2025 | 12.65 Bn |
| Jun 30, 2025 | 12.77 Bn |
| Mar 31, 2025 | 12.61 Bn |
| Dec 31, 2024 | 12.63 Bn |
| Sep 30, 2024 | 12.26 Bn |
| Jun 30, 2024 | 12.01 Bn |
| Mar 31, 2024 | 11.84 Bn |
| Dec 31, 2023 | 12.13 Bn |
| Sep 30, 2023 | 11.60 Bn |
| Jun 30, 2023 | 11.53 Bn |
| Mar 31, 2023 | 11.50 Bn |
| Dec 31, 2022 | 11.85 Bn |
| Sep 30, 2022 | 11.50 Bn |
| Jun 30, 2022 | 11.75 Bn |
| Mar 31, 2022 | 11.85 Bn |
| Dec 31, 2021 | 12.19 Bn |
| Sep 30, 2021 | 12.95 Bn |